"
Impact of cytochrome P450 2C19*2 polymorphism on the clinical cardiovascular events after stent implantation in patients receiving clopidogrel of a southern Tunisian region"
written by Leila Abid, Lobna Laroussi, Amine Bahloul, Ahmed Siala, R. Abdelhédi, Najla Kharrat, Mourad Hentati, Samir Kammoun,
published by
World Journal of Cardiovascular Diseases,
Vol.3 No.1, 2013
has been cited by the following article(s):
|
[1]
|
The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis
Egyptian Journal of Medical Human Genetics,
2022
DOI:10.1186/s43042-022-00313-w
|
|
|
|
|
[2]
|
Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
Scientific Reports,
2022
DOI:10.1038/s41598-022-09679-8
|
|
|
|
|
[3]
|
The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population
Indian Journal of Pharmacology,
2021
DOI:10.4103/ijp.IJP_690_20
|
|
|
|
|
[4]
|
Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients
The Pharmacogenomics Journal,
2021
DOI:10.1038/s41397-021-00231-x
|
|
|
|
|
[5]
|
The clinical effects of CYP2C19 *2 allele frequency on Palestinian patients receiving clopidogrel after percutaneous coronary intervention
International Journal of Clinical Pharmacy,
2019
DOI:10.1007/s11096-018-00782-3
|
|
|
|
|
[6]
|
Allele frequency distribution of CYP2C19*2 allelic variants associated with clopidogrel resistance in cardiac patients
Experimental and Therapeutic Medicine,
2015
DOI:10.3892/etm.2015.2493
|
|
|
|